US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...
Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...
Hosted on MSN8h
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risksThe Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...
Gypsy Rose Blanchard hit back at rumors that Child Protective Services was called to check on her baby Aurora Urker, as well ...
Gypsy-Rose Blanchard exclusively told PEOPLE that she is not using weight-loss drugs to lose weight since giving birth to her ...
The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...
The man in his 40s, who was not identified, had been on the carnivore diet for 8 months when he started to notice the discoloration on the palms of his hands, his elbows and the soles of his feet, ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy can cause relatively minor side effects like ...
Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...
On Friday, however, Novo Nordisk announced top-line results in yet another trial. While the results don't initially sound as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback